Designation of Three High Intensity Drug Trafficking Areas

---
identifier: "/us/fr/2018-09567"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Designation of Three High Intensity Drug Trafficking Areas"
title_number: 0
title_name: "Federal Register"
section_number: "2018-09567"
section_name: "Designation of Three High Intensity Drug Trafficking Areas"
positive_law: false
currency: "2018-05-07"
last_updated: "2018-05-07"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Executive Office of the President"
document_number: "2018-09567"
document_type: "notice"
publication_date: "2018-05-07"
agencies:
  - "Executive Office of the President"
  - "Office of National Drug Control Policy"
fr_citation: "83 FR 20099"
fr_volume: 83
fr_action: "Notice of HIDTA designations."
---


#  Designation of Three High Intensity Drug Trafficking Areas

**AGENCY:**

Office of National Drug Control Policy, Executive Office of the President.

**ACTION:**

Notice of HIDTA designations.

**SUMMARY:**

The Director of the Office of National Drug Control Policy designated three areas as High Intensity Drug Trafficking Areas (HIDTA) pursuant to 21 U.S.C. 1706. These areas are the First, Third, and Fourth Judicial Districts of Alaska.

**FOR FURTHER INFORMATION CONTACT:**

Questions regarding this notice should be directed to Michael K. Gottlieb, National HIDTA Program Director, Office of National Drug Control Policy, Executive Office of the President, Washington, DC 20503; (202) 395-4868.

Dated: May 1, 2018.

Michael J. Passante,

Acting General Counsel.